Are Rheumatologists Diagnosing and Managing Progressive Fibrosing Interstitial Lung Diseases Effectively?
Educational grant support for this session is provided by Boehringer Ingelheim Pharmaceuticals, Inc., and sponsored by Med Learning Group. This is not an official program of the American College of Rheumatology.
Tuesday, November 19, 2024
12:30 PM – 2:00 PM ET simulcast
11:30 AM – 1:00 PM CT
10:30 AM – 12:00 PM MT
9:30 AM – 11:00 AM PT
Program Features:
- Downloadable whiteboard animations
- Interactive, case-based learning environment
- Create-your-own personalized poster
Program Overview
This educational activity aims to help learners assess the key characteristics of progressive fibrosing interstitial lung diseases (PF-ILDs) including idiopathic pulmonary fibrosis (IPF), scleroderma-associated interstitial lung disease (SSc-ILD), and progressive pulmonary fibrosis (PPF); integrate best practices for achieving a timely and accurate diagnosis of PF-ILDs including IPF, SSc-ILD, and PPF; evaluate the potential impact of recent developments in the treatment landscape for PF-ILDs including IPF, SSc-ILD, and PPF; and facilitate multidisciplinary approaches to the diagnosis and management of PF-ILDs including IPF, SSc-ILD, and PPF.
Learning Objectives
After completing the CME activity, learners should be better able to:
- Assess the key characteristics of PF-ILDs including IPF, SSc-ILD, and PPF
- Integrate best practices for achieving a timely and accurate diagnosis of PF-ILDs including IPF, SSc-ILD, and PPF
- Evaluate the potential impact of recent developments in the treatment landscape for PF-ILDs including IPF, SSc-ILD, and PPF
- Facilitate multidisciplinary approaches to the diagnosis and management of PF-ILDs including IPF, SSc-ILD, and PPF
Target Audience
This activity is designed to meet the educational needs of rheumatologists.
Joint Accreditation Statement
Physician Credit Designation Statement
Med Learning Group designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
Nurses (ANCC) Credit Designation
Med Learning Group designates this activity for a maximum of 1.5 ANCC contact hours.
Disclosure Policy Statement
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Disclosure Of Unlabeled Use
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
Disclaimer
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at info@medlearninggroup.com
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event Staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to the live event at info@medlearninggroup.com
Release date: November 19, 2024
Expiration date: November 19, 2024
Estimated time to completion: 1.5 hours
